Zobrazeno 1 - 7
of 7
pro vyhledávání: '"S Y Serebrova"'
Publikováno v:
Терапевтический архив, Vol 91, Iss 5, Pp 134-140 (2019)
One of the serious problems during the treatment of osteoarthritis (OA) is the developing of adverse drug events during therapy. Nonsteroidal anti - inflammatory drugs (NSAIDs) are the first drugs with the high incidence and severity of adverse event
Externí odkaz:
https://doaj.org/article/0519ec9f1a634cf2a3b4721fce08cd5b
Autor:
V. N. Drozdov, E. V. Shikh, A. A. Astapovskiy, Yu. V. Kotlyachkova, L. E. Dobrovolskaya, A. K. Starodubtsev, I. A. Komissarenko, S. Y. Serebrova
Publikováno v:
Медицинский совет, Vol 0, Iss 15, Pp 58-67 (2021)
Chronic pancreatitis is a multifactorial disease in which repeated episodes of inflammation of the pancreas contribute to the development of fibrous tissue, leading to chronic pain, as well as exocrine and endocrine insufficiency. The incidence and p
Externí odkaz:
https://doaj.org/article/60c1c168dcd14901a8ae366b08f50b40
Publikováno v:
Медицинский совет, Vol 0, Iss 3, Pp 92-97 (2019)
Constipation, which is currently one of the global problems of mankind, requires modern approaches to its pharmacological correction. Constipation that occurs in the absence of organic digestive pathology is in most cases considered a symptom of func
Externí odkaz:
https://doaj.org/article/5ca953bc49ce4cfc8e908ec1dff41279
Autor:
A. A. Astapovskiy, Yu. V. Kotlyachkova, S. Y. Serebrova, L. E. Dobrovolskaya, I. A. Komissarenko, E. V. Shikh, A. K. Starodubtsev, V. N. Drozdov
Publikováno v:
Медицинский совет, Vol 0, Iss 15, Pp 58-67 (2021)
Chronic pancreatitis is a multifactorial disease in which repeated episodes of inflammation of the pancreas contribute to the development of fibrous tissue, leading to chronic pain, as well as exocrine and endocrine insufficiency. The incidence and p
Publikováno v:
Медицинский совет, Vol 0, Iss 13, Pp 90-93 (2015)
The article tells about intermediate results of a comparative study of the efficacy and tolerability of Lavacol® in the treatment of chronic constipation. The treatment group consisted of patients receiving Lavacol®, and the control group included
Externí odkaz:
https://doaj.org/article/37112f09cfcf42df81fdf85bd1397739
Publikováno v:
Терапевтический архив, Vol 91, Iss 5, Pp 134-140 (2019)
One of the serious problems during the treatment of osteoarthritis (OA) is the developing of adverse drug events during therapy. Nonsteroidal anti - inflammatory drugs (NSAIDs) are the first drugs with the high incidence and severity of adverse event
Publikováno v:
Kardiologiia. (10)
In this article we have described clinical pharmacology and data of clinical studies of an innovational drug valsartan + sacubitril in patients with chronic heart failure (CHF). The use of supramolecular complex valsartan + sacubitril allows to eleva